In the case of ovarian cancer, it induces cell apoptosis and increases sensitivity to cisplatin, even reverses cisplatin resistance, through the cAMP/PKA/CREB-FtMt signaling axis (55). The gene discussed is FTMT; the disease is ovarian carcinoma.